Armenia’s food safety body checks 11 dairy companies
The inspectorate says it began checks after independent testing found microbiological problems in the companies’ products and plans to publish the results.
Loading… Բեռնվում է…
The inspectorate says it began checks after independent testing found microbiological problems in the companies’ products and plans to publish the results.
Armenia’s Food Safety Inspection Body says it is checking all 11 dairy companies whose products were found to have microbiological problems in recent independent testing. The body treated the publication of the findings as an alert and says it will publish the results of its checks.
The statement followed a journalist’s concern at Prime Minister Nikol Pashinyan’s briefing that the responsible authority was not warning the public or stopping sales of dangerous food. The inspectorate called the concern unfounded and said it had publicized all detected problems and suspension decisions. It directed readers to its website and social media pages. Civic.am published the body’s response.
The body said that in 2026 it conducted 120 planned inspections at dairy production facilities and specialized sales outlets, resulting in 25 suspension decisions. It also conducted 86 unplanned inspections and found violations in 37 of them. These figures are the body’s wider inspection record, not announced results from the current checks.
The body said most suspensions were linked to an indicator it calls «ԱՑԽՄ», which it described as a consequence of secondary contamination.
The unplanned total includes repeat inspections: the body said an organization can be checked several times depending on laboratory results. The number therefore does not represent a count of distinct companies.
The inspectorate has not announced a date for publishing the results of the ongoing checks.
Webb observations show an unusual absorption pattern in the interstellar comet. A study favors grains of ice mixed with dust, about a micron or smaller, as an explanation.
3 min
Flu activity remained low in the week through 1 November, while hospital admissions for RSV rose and those for COVID-19 fell.
1 min
STAT says a real-world-evidence trial favored the injectable cholesterol drug and describes a 20% reduction in heart attack risk.
1 min
